Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Editas Medicine | 679 | 2023q3 | |||||||||
Edwards Lifesciences | 37,427 | 2023q3 | |||||||||
Elanco Animal Health | 5,273 | 2023q3 | |||||||||
Elevance Health | 115,256 | 2024q3 | |||||||||
Eli Lilly and Co | 790,100 | 2023 | |||||||||
Emergent BioSolutions | 110 | 2023q3 | |||||||||
Enanta Pharmaceuticals | 201 | 2023q3 | |||||||||
Encompass Health | 6,271 | 2023q3 | |||||||||
Ensign Group | 8,359 | 2023q3 | |||||||||
Esperion Therapeutics | 239 | 2023q3 | |||||||||
Eton Pharmaceuticals | 98 | 2021 | |||||||||
Evotec | 2,502 | 2021 | |||||||||
EXACT Sciences | 10,769 | 2023q1 | |||||||||
Exelixis | 6,828 | 2023 | |||||||||
Fate Therapeutics | 239 | 2023q3 | |||||||||
FibroGen | 33 | 2023q2 | |||||||||
Foghorn Therapeutics | 338 | 2023q3 | |||||||||
FONAR | 159 | 2024q1 | |||||||||
Fresenius Medical Care AG... | 14,605 | 2023q2 | |||||||||
Fresenius SE & Co | 19,896 | 2021 |